NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual ...
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...
Pharmaceutical Technology on MSN
Genentech secures FDA approval for Lunsumio VELO SC for follicular lymphoma
Genentech, a subsidiary of the Roche Group, has received the US Food and Drug Administration’s (FDA) accelerated approval for ...
Complications from an epidural injection led to a wrongful death suit against MUSC in Charleston and ultimately a payout by ...
Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct strengths and limitations. IV administration offers established dosing precision, ...
Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).
Since executions resumed in Sept. 2024, seven men have been executed by lethal injection and firing squad in South Carolina.
Lerochol is a third-generation PCSK9 inhibitor approved for reducing LDL cholesterol in adults with hypercholesterolemia, including HeFH. The drug offers a convenient once-monthly subcutaneous ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...
The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...
In April 2023, Samsung discovered its engineers had leaked sensitive information to ChatGPT. But that was accidental. Now imagine if those code repositories had contained deliberately planted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results